Market
Maca extract (from Lepidium meyenii) is marketed in Ecuador primarily within the regulated dietary-supplement space, where plant concentrates and extracts are explicitly within scope. For products positioned as "suplementos alimenticios", Ecuador requires an ARCSA Notificación Sanitaria prior to importation and commercialization, supported by label, quality-specification, and dossier requirements. A key market-access issue is correct product positioning and claims: therapeutic claims are restricted for supplements and can trigger reclassification into stricter medicinal natural-product pathways. Because Lepidium meyenii is native to the southern Andes (not Ecuador), Ecuador supply for maca extract is typically import-led or sourced from regional Andean producers.
Market RoleImport-dependent consumer and supplement market
Domestic RoleCommercialized as dietary supplements (including botanical extracts) under ARCSA sanitary notification controls; may also be positioned as a natural medicinal product if therapeutic claims are made
Risks
Regulatory Compliance HighEcuador market entry can be blocked if maca extract products are imported/commercialized as suplementos alimenticios without an ARCSA Notificación Sanitaria and the supporting dossier (Spanish labeling, quality specifications, and import-specific documentation). Misclassification and/or therapeutic claims inconsistent with the supplement framework can escalate requirements (e.g., into medicinal natural-product registration routes) and lead to rejection, withdrawal, or sanctions.Define intended product positioning and claims before shipment; align labeling/claims to the applicable ARCSA pathway (supplement vs medicinal natural product), secure the ARCSA notification/registration in advance, and complete the dossier (labels, manufacturing description, specifications, and legalized foreign certificates where required).
Food Safety MediumARCSA supplement requirements reference physicochemical and microbiological specifications (including parameters such as aflatoxins and heavy metals) and can trigger enforcement actions if declared specifications and actual product performance are inconsistent or unsupported.Implement a pre-shipment quality file including current CoA (microbiology + heavy metals/aflatoxin where relevant), stability/shelf-life basis, and packaging material specs; retain batch-level documentation for audit.
Documentation Gap MediumImport clearance delays can occur if ECUAPASS DAI filings lack required supporting/accompanying documents or if data (weights, ports, freight, invoices, product IDs) is inconsistent across documents, requiring corrections or rejection workflows.Run a pre-filing document reconciliation checklist (invoice, transport doc, ARCSA notification/registration evidence, legalized foreign certificates if applicable) and file DAI within the stated time windows using an experienced customs agent.
Marketing Claims MediumSupplement labeling/advertising that implies treatment or cure of diseases is restricted; non-compliant claims can drive enforcement action and/or force reclassification into medicinal regulatory pathways with different evidentiary and GMP requirements.Keep claims within permissible nutrition/health claim frameworks and maintain substantiation aligned to INEN 1334-3 or recognized references accepted by ARCSA; conduct a label/claims legal review before launch.
Standards- WHO GMP for herbal medicines (relevant if the product is positioned/regulated as a medicinal herbal/natural product pathway rather than a dietary supplement)
FAQ
Does Ecuador require an ARCSA sanitary authorization to import and sell maca extract supplements?Yes. For products marketed as “suplementos alimenticios” (including plant concentrates and extracts), ARCSA requires obtaining a Notificación Sanitaria before the product can be imported and commercialized in Ecuador, along with a supporting dossier (e.g., Spanish labels and product specifications).
What botanical identification details are expected in the Ecuador supplement dossier for maca-based products?ARCSA’s supplement requirements indicate that when vegetable species are used as ingredients, the dossier should state the scientific name and the part of the plant used as part of the qualitative-quantitative formulation declaration.
Which HS heading is commonly used as a starting point for classifying plant extracts like maca extract?HS heading 1302 covers “vegetable saps and extracts” and is a common starting point for plant-extract classification, but the correct HS code must be confirmed based on the specific extract and intended use.